HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 246 filers reported holding HAEMONETICS CORP in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $354,647 | +5.7% | 3,959 | +0.5% | 0.01% | +9.1% |
| Q2 2023 | $335,367 | +2.9% | 3,939 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $325,952 | +106073.3% | 3,939 | +0.8% | 0.01% | 0.0% |
| Q4 2022 | $307 | -99.9% | 3,909 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $290,000 | +13.7% | 3,909 | -0.4% | 0.01% | +22.2% |
| Q2 2022 | $255,000 | +3.7% | 3,926 | +1.0% | 0.01% | +12.5% |
| Q1 2022 | $246,000 | +18.3% | 3,888 | -0.9% | 0.01% | +33.3% |
| Q4 2021 | $208,000 | -24.9% | 3,923 | -0.0% | 0.01% | -45.5% |
| Q3 2021 | $277,000 | +5.3% | 3,924 | -0.8% | 0.01% | 0.0% |
| Q2 2021 | $263,000 | -64.1% | 3,955 | -40.1% | 0.01% | -65.6% |
| Q1 2021 | $732,000 | -6.9% | 6,600 | -0.3% | 0.03% | -11.1% |
| Q4 2020 | $786,000 | +228.9% | 6,617 | +141.9% | 0.04% | +200.0% |
| Q3 2020 | $239,000 | +305.1% | 2,735 | +363.6% | 0.01% | +200.0% |
| Q4 2018 | $59,000 | -35.2% | 590 | -25.8% | 0.00% | -20.0% |
| Q3 2018 | $91,000 | – | 795 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |